We also observed decreased miR-29a-3p expression and enhanced LTβR expression in GC, and determined that this HOXA-AS3 was able to negatively regulate miR-29a-3p and to thereby promote LTβR upregulation, thus driving GC progression via NF-κB pathway activation. The gene discussed is NFKB1; the disease is gastric cancer.